NASDAQ Biotechnology Stock
We commenced our
operations in 1979 and launched our first products, dipstick based pregnancy
tests, in 1984. Our product base and technology platforms have expanded through
internal development and acquisitions of other products and technologies. We have
a worldwide leadership position in the development, manufacturing and marketing
of rapid diagnostic solutions at the professional ...
more
Our company is based on the vision of providing a higher quality of healthcare through advanced diagnostic products. Our business strategy is to assemble
the companies, products and knowledge base to become a leading supplier of the technologies and products that will help drive a new era of personalized medicine. We were early to recognize that the adoption of personalized medicine is ...
more
Lexicon Genetics is a biopharmaceutical company focused on the discovery and development of
breakthrough treatments for human disease. We use our proprietary gene knockout technology to
knock out, or disrupt, the function of genes in mice and then employ an integrated platform of
advanced medical technologies to systematically ...
more
TECHNE Corporation (the Company) is a holding company which has two wholly- owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (R&D Europe) located in Abingdon, England. R&D Systems is a specialty manufacturer of biological products. Its two major operating segments are hematology controls, which ...
more
Our disclosure and analysis in this Annual Report on Form 10-K contains some forward-looking statements. Forward-looking statements give our current
expectations or forecasts of future events. You can identify these statements since they do not relate strictly to historical or current facts. Such statements may include words such as “anticipate,” “estimate,” ...
more
Thermogenesis Corporation engages in the development and sale of automated and semi-automated devices used to process, cryopreserve and store therapeutic doses of adult stem cells for treatment of disease and injury.
more
Our InForm , Clintrial
and Clintrace software solutions
are generally provided to our customers for enterprise adoption through
multi-year term licenses of generally three to five years with periodic fees. Our
WebVDME, CTSD and WebSDM software solutions are generally
provided to our customers through annual licenses or multi-year term licenses
of two to three years. We also offer ...
more
We are a biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other
critical health challenges for which there are few other treatment options. Our expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the ...
more
We develop, manufacture and market our proprietary gene-based diagnostic tests for the
screening, monitoring and diagnosis of human diseases. Our primary focus is in women’s cancers and
infectious diseases. We have applied our proprietary Hybrid Capture ® technology to develop a
successful diagnostic test for human papillomavirus (HPV), which is the ...
more
Renovis is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases. We apply our
integrated capabilities in preclinical research and development, including molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism and ...
more
We are a specialty pharmaceutical company focused on acquiring, developing and commercializing
proprietary products that address the needs of patients treated by gastroenterologists or primary
care physicians. The primary focus of our current efforts is the commercialization of proprietary
immediate-release proton pump inhibitor, or PPI, products. PPI products are ...
more
Impax Laboratories, Inc. ("we," "us," "our," "the Company" or "IMPAX") is a specialty pharmaceutical company focused on the development and commercialization of specialty generic and branded pharmaceuticals, utilizing our in-house development and formulation expertise. In the specialty generic pharmaceuticals market, we are focusing our efforts on selected controlled-release generic versions ...
more
This report includes forward-looking statements. In particular, statements about our
expectations, beliefs, plans, objectives or assumptions of future events or performance are
contained or incorporated by reference in this report. We have based these forward-looking
statements on our current expectations about future events. While we believe these expectations ...
more
You also may read and copy any materials we file with
the SEC at the SEC’s Public Reference Room at 450 Fifth Street, NW,
Washington, DC, 20549. You may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330.
The SEC maintains an Internet site (www.sec.gov) that contains reports, proxy
and information statements, and other ...
more
We develop, acquire and commercialize novel treatments for cancer. Our goal is to build a leading biopharmaceutical company with a diversified portfolio
of proprietary oncology drugs. Our research, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and more effective ways to treat cancer.
more
